CRISPR Therapeutics(CRSP) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist

40.070
-0.820-2.01%

Trading Mar 26 10:55 ET

3.44BMarket Cap-9.23P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

This CRISPR Therapeutics Insider Increased Their Holding In The Last Year
Yahoo Finance06:33 ET
BMO Capital Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating, Maintains Target Price $97
Moomoo News02:33 ET · Ratings
Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts
Yahoo Finance17:40 ET
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
BNN Bloomberg13:51 ET
Buy Rating for Crispr Therapeutics AG Driven by Promising Clinical Data and Diversified Pipeline
TipRanksMar 25 07:05 ET · Ratings
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
Barron'sMar 25 00:01 ET

Comments

Moomoo News Global

Feb 21 20:16

Columns HIMS Jumps 174% YTD — Who's Next?

$Hims & Hers Health (HIMS.US)$ , an online health and wellness platform, has seen its stock soar over 78% since February, with a year-to-date surge exceeding 174%. This outpaces the projected full-year gain of 171% for 2024.
What's Fueling HIMS' Rally?
HIMS surged 17.5% on Wednesday following the announcement of an acquisition, reaching an intraday high of nearly 25% and hitting a record $72.
Hims & Hers disclosed it acquired Sigmund NJ LLC, also known as Trybe La...